You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HIF2α

Showing 1 - 25 of 7,722
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)

Active, not recruiting
  • Advanced Solid Tumors
  • +15 more
  • (no location specified)
Sep 16, 2022

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)

Recruiting
  • ccRCC
  • +9 more
  • Oral NKT2152
  • Scottsdale, Arizona
  • +6 more
Oct 17, 2022

Clear Cell Renal Cell Carcinoma Trial in Boston (Abemaciclib, MK-6482)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +1 more
Dec 14, 2022

Carcinoma, Renal Cell Trial in Worldwide (DFF332, RAD001, PDR001)

Recruiting
  • Carcinoma, Renal Cell
  • Duarte, California
  • +10 more
Jun 13, 2022

CITED2 and Collateral Circulation in Acute Ischemic Stroke

Completed
  • Acute Ischemic Stroke
  • non-applicable
  • Guangzhou, Guangdong, China
    Zhujiang Hospital
Apr 19, 2022

ccRCC, RCC, Kidney Cancer Trial in United States (MK-3795, Nivolumab, Cabozantinib)

Active, not recruiting
  • ccRCC
  • +4 more
  • Los Angeles, California
  • +24 more
Jul 18, 2022

Hypoxia-induced Autophagy in the Pathogenesis of MAP

Not yet recruiting
  • Hypoxia
  • +3 more
  • HIF 1α and LC3B expression and MMP-9 level
  • (no location specified)
Apr 5, 2023

Post Covid-19 Hypoxia on Placenta of Normal Pregnant Women: A

Not yet recruiting
  • Hif-1α Covid-19
  • HiF-1 alpha measurement
  • (no location specified)
Dec 14, 2021

Polycythemia; Familial, Erythrocytosis; Familial, VHL Gene Mutation Trial (Digoxin)

Not yet recruiting
  • Polycythemia; Familial
  • +5 more
  • (no location specified)
Feb 2, 2022

Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

Recruiting
  • Polycythemia Vera
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
May 19, 2023

Schizophrenia Trial ([18F]ASEM, [18F]AZAN)

Not yet recruiting
  • Schizophrenia
  • (no location specified)
Aug 2, 2022

Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in Dallas ([18F]PT2385, Positron Emission Tomography/Computed

Recruiting
  • Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma
  • Dallas, Texas
    UT Southwestern Medical Center
Aug 23, 2021

Herpes Zoster Trial (Recombinant Human Interferon a-2b Gel (After the Alteration), Recombinant Human Interferon a-2b Gel (Before

Not yet recruiting
  • Herpes Zoster
  • Recombinant Human Interferon α-2b Gel (After the Alteration)
  • Recombinant Human Interferon α-2b Gel (Before the Alteration)
  • (no location specified)
Apr 7, 2023

COVID-19, Children Trial in Shanghai (Inhaled Interferon a2b, Standard of Care)

Recruiting
  • COVID-19
  • Children
  • Inhaled Interferon α2b
  • Standard of Care
  • Shanghai, China
    Children Hospital of Fudan University
May 18, 2022

Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +2 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023

Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)

Recruiting
  • Hepatitis B, Chronic
  • PEGylated recombinant human interferon alpha-2b injection
  • Hefei, Anhui, China
    The First Affiliated Hospital of Anhui Medical University
Jun 24, 2023

Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)

Completed
  • Chronic Hepatitis B
  • PegIFN α- 2b
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 11, 2022

Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)

Not yet recruiting
  • Chronic Hepatitis B
  • PEG IFN α-2b; TAF
  • (no location specified)
Aug 5, 2022

Coronavirus Disease 2019 Trial in Santiago (Interferon-Alpha2B, Placebo)

Completed
  • Coronavirus Disease 2019
  • Santiago, RM, Chile
    Red de Salud UC Christus
Aug 3, 2022

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,

Recruiting
  • Neuroendocrine Tumors
  • +4 more
  • [212Pb] VMT-α-NET
  • [203Pb] VMT-α-NET SPECT/CT
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center at the University of Iowa
Nov 30, 2023

Lymphoma, B-Cell Trial in Guangzhou (Rituximab Biosimilar, Pegylated Interferon a-2b)

Recruiting
  • Lymphoma, B-Cell
  • Rituximab Biosimilar
  • Pegylated Interferon α-2b
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-sen University Cancer Ce
Apr 6, 2022

Periodontal Diseases Trial in Konya (ELISA)

Completed
  • Periodontal Diseases
  • ELISA
  • Konya, Turkey
    Necmettin Erbakan University
May 7, 2023

Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)

Enrolling by invitation
  • Neuroendocrine Tumor Grade 2
  • Neuroendocrine Tumor Grade 1
  • Iowa City, Iowa
    The University of Iowa
Dec 9, 2022

Acute Ischemic Stroke Trial in Shanghai

Completed
  • Acute Ischemic Stroke
    • Shanghai, China
      Shanghai Sixth People's Hospital
    Aug 8, 2020

    Cirrhosis, Liver Trial (Healthy fecal bacteria liquid)

    Unknown status
    • Cirrhosis, Liver
    • Healthy fecal bacteria liquid
    • (no location specified)
    Oct 11, 2020